China Chemical & Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
China Chemical & Pharmaceutical has a total shareholder equity of NT$7.5B and total debt of NT$3.1B, which brings its debt-to-equity ratio to 41.8%. Its total assets and total liabilities are NT$12.8B and NT$5.3B respectively. China Chemical & Pharmaceutical's EBIT is NT$295.9M making its interest coverage ratio 7.7. It has cash and short-term investments of NT$510.7M.
Key information
41.8%
Debt to equity ratio
NT$3.14b
Debt
Interest coverage ratio | 7.7x |
Cash | NT$510.65m |
Equity | NT$7.50b |
Total liabilities | NT$5.31b |
Total assets | NT$12.80b |
Recent financial health updates
We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt
Apr 07Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?
Jan 06Recent updates
Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching
Apr 25We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt
Apr 07The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On
Mar 17China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Feb 24Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?
Jan 27Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?
Jan 06The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On
Dec 16China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 26Financial Position Analysis
Short Term Liabilities: 1701's short term assets (NT$5.6B) exceed its short term liabilities (NT$3.6B).
Long Term Liabilities: 1701's short term assets (NT$5.6B) exceed its long term liabilities (NT$1.7B).
Debt to Equity History and Analysis
Debt Level: 1701's net debt to equity ratio (35%) is considered satisfactory.
Reducing Debt: 1701's debt to equity ratio has reduced from 53.4% to 41.8% over the past 5 years.
Debt Coverage: 1701's debt is not well covered by operating cash flow (18.2%).
Interest Coverage: 1701's interest payments on its debt are well covered by EBIT (7.7x coverage).